InvestorsHub Logo
Followers 5
Posts 715
Boards Moderated 0
Alias Born 11/16/2022

Re: None

Thursday, 09/14/2023 7:02:46 PM

Thursday, September 14, 2023 7:02:46 PM

Post# of 463447
Let’s ASSUME that all the information in the PR is absolutely accurate. Then what?

I’d say then it’s reasonably convincing for AA and/or even full approval — except for one addition issue: data on different dosage arms (note that the drug can only be approved for a specific dosage — so pooled analysis must not be sufficient).

In spite of all the missing information in the PR, the AD situation is certainly much better now than before.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News